Zurcher Kantonalbank (Zurich Cantonalbank) Biotechnology

Zurcher Kantonalbank (Zurich Cantonalbank)

$39 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PTGX Protagonist Therapeutics, Inc	$4.27B	$556,000 0.0% of portfolio	10,073	Q2 2025 Added 10.79%
BEAM Beam Therapeutics Inc.	$1.85B	$553,000 0.0% of portfolio	32,534	Q2 2025 Added 25.43%
AGIO Agios Pharmaceuticals, Inc.	$2.23B	$545,000 0.0% of portfolio	16,396	Q2 2025 Added 27.73%
KRYS Krystal Biotech, Inc.	$4.66B	$531,000 0.0% of portfolio	3,864	Q2 2025 Reduced 32.71%
ARWR Arrowhead Pharmaceuticals, Inc.	$3.75B	$529,000 0.0% of portfolio	33,517	Q2 2025 Reduced 0.24%
BCRX Biocryst Pharmaceuticals Inc	$1.34B	$520,000 0.0% of portfolio	58,095	Q2 2025 Reduced 0.21%
NVO Novo Nordisk A S	$129B	$476,000 0.0% of portfolio	6,899	Q2 2025 Added 1,065.37%
CRNX Crinetics Pharmaceuticals, Inc.	$2.42B	$462,000 0.0% of portfolio	16,081	Q2 2025 Added 9.45%
IDYA Ideaya Biosciences, Inc.	$1.26B	$444,000 0.0% of portfolio	21,170	Q2 2025 Reduced 0.61%
SRPT Sarepta Therapeutics, Inc.	$1.94B	$443,000 0.0% of portfolio	25,941	Q2 2025 Added 9.4%
RXRX Recursion Pharmaceuticals, Inc.	$960M	$437,000 0.0% of portfolio	86,497	Q2 2025 Added 12.73%
ADPT Adaptive Biotechnologies Corp	$2.17B	$425,000 0.0% of portfolio	36,551	Q2 2025 Reduced 0.55%
ARQT Arcutis Biotherapeutics, Inc.	$1.21B	$414,000 0.0% of portfolio	29,565	Q2 2025 Reduced 0.44%
AVXL Anavex Life Sciences Corp.	$723M	$406,000 0.0% of portfolio	44,108	Q2 2025 Added 134.72%
CLDX Celldex Therapeutics, Inc.	$1.25B	$387,000 0.0% of portfolio	19,060	Q2 2025 Added 19.65%
VERA Vera Therapeutics, Inc.	$814M	$385,000 0.0% of portfolio	16,343	Q2 2025 Added 71.44%
TVTX Travere Therapeutics, Inc.	$1.61B	$380,000 0.0% of portfolio	25,728	Q2 2025 Added 12.08%
VRDN Viridian Therapeutics, Inc.\De	$837M	$377,000 0.0% of portfolio	26,968	Q2 2025 Added 44.49%
AUPH Aurinia Pharmaceuticals Inc.	$1.6B	$359,000 0.0% of portfolio	42,496	Q2 2025 Reduced 0.34%
IMVT Immunovant, Inc.	$3.55B	$358,000 0.0% of portfolio	13,044	Q1 2025 Added 66.29%
FOLD Amicus Therapeutics, Inc.	$2.33B	$344,000 0.0% of portfolio	60,189	Q4 2024 Added 19.25%
ETNB 89bio, Inc.	$688M	$342,000 0.0% of portfolio	34,890	Q2 2025 Added 71.91%
SVRA Savara Inc	$384M	$340,000 0.0% of portfolio	149,427	Q2 2025 Added 147.63%
WVE Wave Life Sciences Ltd.	$660M	$339,000 0.0% of portfolio	52,303	Q2 2025 Added 24.61%
APLS Apellis Pharmaceuticals, Inc.	$2.76B	$331,000 0.0% of portfolio	19,128	Q2 2025 Reduced 3.84%
NTLA Intellia Therapeutics, Inc.	$1.86B	$331,000 0.0% of portfolio	35,328	Q2 2025 Reduced 3.99%
ARDX Ardelyx, Inc.	$764M	$329,000 0.0% of portfolio	83,947	Q2 2025 Added 15.85%
MNKD Mannkind Corp	$1.26B	$329,000 0.0% of portfolio	88,067	Q2 2025 Reduced 11.4%
ABUS Arbutus Biopharma Corp	$616M	$310,000 0.0% of portfolio	100,338	Q2 2025 Added 19.22%
RCUS Arcus Biosciences, Inc.	$1.05B	$291,000 0.0% of portfolio	35,771	Q2 2025 Added 0.06%
JANX Janux Therapeutics, Inc.	$1.1B	$291,000 0.0% of portfolio	12,604	Q2 2025 Added 76.9%
LGND Ligand Pharmaceuticals Inc	$3B	$284,000 0.0% of portfolio	2,504	Q2 2025 Reduced 0.48%
QURE Uni Qure N.V.	$2.88B	$276,000 0.0% of portfolio	19,804	Q2 2025 Added 706.35%
HRMY Harmony Biosciences Holdings, Inc.	$1.57B	$258,000 0.0% of portfolio	8,177	Q4 2024 Added 58.81%
MDXG Mimedx Group, Inc.	$744M	$242,000 0.0% of portfolio	39,713	Q1 2025 Added 18.11%
TARS Tarsus Pharmaceuticals, Inc.	$1.87B	$233,000 0.0% of portfolio	5,755	Q2 2025 Added 19.42%
DAWN Day One Biopharmaceuticals, Inc.	$532M	$214,000 0.0% of portfolio	32,939	Q2 2025 Added 130.84%
NRIX Nurix Therapeutics, Inc.	$460M	$214,000 0.0% of portfolio	18,829	Q1 2025 Added 13.64%
XNCR Xencor Inc	$778M	$212,000 0.0% of portfolio	27,090	Q2 2025 Added 31.02%
VIR Vir Biotechnology, Inc.	$769M	$204,000 0.0% of portfolio	40,668	Q2 2025 Reduced 0.79%
OCUL Ocular Therapeutix, Inc	$907M	$198,000 0.0% of portfolio	21,415	Q2 2025 Reduced 32.53%
IMNM Immunome Inc.	$169M	$196,000 0.0% of portfolio	21,154	Q2 2025 Added 164.06%
SNDX Syndax Pharmaceuticals Inc	$908M	$192,000 0.0% of portfolio	20,541	Q2 2025 Added 54.91%
KURA Kura Oncology, Inc.	$659M	$189,000 0.0% of portfolio	32,784	Q1 2025 Added 23.11%
CRMD Cor Medix Inc.	$442M	$184,000 0.0% of portfolio	14,983	Q2 2025 Reduced 1.04%
DYN Dyne Therapeutics, Inc.	$727M	$183,000 0.0% of portfolio	19,247	Q1 2025 Added 22.2%
CVAC Cure Vac N.V.	$1.01B	$158,000 0.0% of portfolio	29,253	Q2 2025 Added 0.44%
COGT Cogent Biosciences, Inc.	$1.07B	$150,000 0.0% of portfolio	20,918	Q2 2025 Added 197.81%
GERN Geron Corp	$495M	$145,000 0.0% of portfolio	103,230	Q2 2025 Reduced 39.43%
CAPR Capricor Therapeutics, Inc.	$173M	$134,000 0.0% of portfolio	13,591	Q2 2025 Added 2.6%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.